title: [The value of multiplex fluorescence in situ hybridization in the detection of complex karyotypic abnormalities of acute myeloid leukemia].
abstract: OBJECTIVE
  To investigate the value of multiplex fluorescence in situ hybridization (FISH) in the detection of complex karyotypic abnormalities of acute myeloid leukemia (AML).
  
  
  METHODS
  Multiplex FISH was used in combination with conventional cytogenetics (CC) and interphase FISH to study 14 cases of AML with complex karyotypic abnormalities.
  
  
  RESULTS
  In the 14 cases of AML studied, conventional cytogenetics detected 23 numerical and 56 structural chromosome abnormalities. Among them 4 gained whole chromosome and 4 lost whole chromosome which were confirmed by multiplex FISH. Twelve chromosome losses detected by CC were revised as derivative chromosomes resulted from various structural aberrations, and 26 derivative and 19 marker chromosomes were characterized precisely by multiplex FISH. Most of them were resulted from unbalanced translocations, including 2 complex 8; 21 translocations, which have not been reported previously: t (8; 21), der (8) t (8; 21) (8pter --> 8q22::21q22 --> 21qter), der (21) t (8; 21; 8) (8qter --> 8q22:: 21p13 --> 21q22::8q22 --> 8qter) and t (21; 8; 18; 1), der (8) t (8; 21) (8pter --> 8q22:: 21q22 --> 21qter), der (21) t (21; 8; 18; 1) (21p13 --> 21q22?::8q22 --> 8q24 ?:: 18??::1q??q??). The complex karyotypic abnormalities involved nearly all chromosomes, of which the chromosomes 17, 7 and 5 were more involved than the rest.
  
  
  CONCLUSIONS
  Multiplex FISH in combination with conventional cytogenetics may characterize the complex chromosomal abnormalities more precisely. Introduction of this technique to the study of AML with complex chromosomal abnormalities is warranted.
authors.affiliation: Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.
authors.forename: Li
authors.initials: L
authors.lastname: Ma
authors.forename: Jian-yong
authors.initials: JY
authors.lastname: Li
authors.forename: Jin-lan
authors.initials: JL
authors.lastname: Pan
authors.forename: Bing
authors.initials: B
authors.lastname: Xiao
authors.forename: Si-xuan
authors.initials: SX
authors.lastname: Qian
authors.forename: Li-juan
authors.initials: LJ
authors.lastname: Chen
authors.forename: Hai-rong
authors.initials: HR
authors.lastname: Qiu
authors.forename: Bing-zhao
authors.initials: BZ
authors.lastname: Wen
authors.forename: Yong-quan
authors.initials: YQ
authors.lastname: Xue
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D032681:Spectral Karyotyping / Q000379:methods*; D014178:Translocation, Genetic; D055815:Young Adult